Metformin Can Alleviate the Symptom of Patient with Diabetic Nephropathy Through Reducing the Serum Level of Hcy and IL-33

BACKGROUND: Interleukin-33 (IL-33) and homocysteine (Hcy) were found to be up-regulated in patients with diabetic nephropathy (DN), and the present study aimed to investigate whether metformin (MT) can influence the serum levels of IL-33 and Hcy in patients with DN. METHODS: Sixty patients with type...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ling, Niu, Jiansheng, Zhang, Xiumei, He, Wanxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731542/
https://www.ncbi.nlm.nih.gov/pubmed/31535033
http://dx.doi.org/10.1515/med-2019-0071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731542/
https://www.ncbi.nlm.nih.gov/pubmed/31535033
http://dx.doi.org/10.1515/med-2019-0071

Ejemplares similares